WALSH MATTHEW M 4

What Happened

• Matthew M. Walsh, Chief Financial Officer of Organon & Co. (OGN), had 15,071 restricted stock units (RSUs) convert to common shares on March 29, 2026.
• Of those 15,071 shares, 5,162 shares were surrendered to cover tax withholding at the plan-specified price of $5.84 (total value withheld ≈ $30,146). The remaining 9,909 shares were delivered to Walsh.
• This was not a market purchase or sale for investment — it was a routine RSU vesting and tax-withholding event.

Key Details

• Transaction date: March 29, 2026; Form 4 filed March 31, 2026 (appears timely under the two-business-day rule).
• Amounts: 15,071 RSUs converted to shares (code M); 5,162 shares withheld for taxes (code F) at $5.84/share = $30,146. Net shares received: 9,909.
• Footnotes: F1 — $5.84 is the closing market price on March 27, 2026 as required by the plan; F2 — each RSU equals one share upon conversion; F3 — these RSUs vest in three equal annual installments (Mar 29, 2025; Mar 29, 2026; Mar 29, 2027).
• Shares owned following the reported transaction: not specified in the filing.

Context

• This was a routine RSU vesting and tax-withholding (cashless) transaction — common compensation-related activity and not an open‑market buy or sell.
• Transaction codes: M = exercise/conversion of a derivative (here, RSU → share); F = payment of exercise price or tax liability (shares withheld for taxes).
• Such vesting events reflect compensation realization, not necessarily a signal of personal market sentiment.